Dr Jodie Ingles

Conjoint Senior Lecturer
Centenary Institute of Cancer Medicine & Cell Biology, Central Clinical School

Telephone 02 9565 6293

Map

Selected grants

2014

  • Clinical, Genetic and Psychosocial Aspects of Sudden Cardiac Death; Ingles J; National Health and Medical Research Council (NHMRC)/Project Grants.

2013

  • Genetic testing in children at risk of genetic heart disease: optimizing clinical care; Ingles J, Semsarian C; Thrasher Research Fund/Research Support.

2012

  • Management of families with a genetic cause of sudden cardiac death; Ingles J; National Health and Medical Research Council (NHMRC)/Early Career Fellowships (ECF).

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Ingles, J., Semsarian, C. (2014). Conveying a probabilistic genetic test result to families with an inherited heart disease. Heart Rhythm, 11(6), 1073-1078. [More Information]
  • Das K, J., Ingles, J., Bagnall, R., Semsarian, C. (2014). Determining pathogenicity of genetic variants in hypertrophic cardiomyopathy: importance of periodic reassessment. Genetics in Medicine, 16(4), 286-293. [More Information]
  • Ingles, J., Semsarian, C. (2014). The value of cardiac genetic testing. Trends In Cardiovascular Medicine, 24(6), 217-224. [More Information]
  • Ingles, J., Sarina, T., Yeates, L., Hunt, L., Macciocca, I., McCormack, L., Winship, I., McGaughran, J., Atherton, J., Semsarian, C. (2013). Clinical predictors of genetic testing outcomes in hypertrophic cardiomyopathy. Genetics in Medicine, 15(12), 972-977. [More Information]
  • Semsarian, C., Ingles, J. (2013). Expanding the genetic spectrum of hypertrophic cardiomyopathy: x marks the spot. Circulation Cardiovascular Genetics, 6(6), 528-530. [More Information]
  • Ingles, J., Yeates, L., Hunt, L., McGaughran, J., Scuffham, P., Atherton, J., Semsarian, C. (2013). Health status of cardiac genetic disease patients and their at-risk relatives. International Journal of Cardiology, 165(3), 448-453. [More Information]
  • Gray, B., Yeates, L., Medi, C., Ingles, J., Semsarian, C. (2013). Homozygous mutation in the cardiac troponin I gene: Clinical heterogeneity in hypertrophic cardiomyopathy. International Journal of Cardiology, 168(2), 1530-1531. [More Information]
  • Yeates, L., Hunt, L., Saleh, M., Semsarian, C., Ingles, J. (2013). Poor psychological wellbeing particularly in mothers following sudden cardiac death in the young. European Journal of Cardiovascular Nursing, 12(5), 484-491. [More Information]
  • Gray, B., Ingles, J., Medi, C., Semsarian, C. (2013). Prolongation of the QTc Interval Predicts Appropriate Implantable Cardioverter-Defibrillator Therapies in Hypertrophic Cardiomyopathy. JACC: Heart Failure, 1(2), 149-155. [More Information]
  • Ingles, J., Sarina, T., Kasparian, N., Semsarian, C. (2013). Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease. International Journal of Cardiology, 168(4), 3779-3784. [More Information]
  • Ingles, J., Semsarian, C. (2013). The Australian Genetic Heart Disease Registry. International Journal of Cardiology, 168(4), e127-e128. [More Information]
  • Redfern, J., Ingles, J., Neubeck, A., Johnston, S., Semsarian, C. (2013). Tweeting Our Way to Cardiovascular Health. Journal of the American College of Cardiology, 61(15), 1657-1658. [More Information]
  • Ingles, J., McGaughran, J., Scuffham, P., Atherton, J., Semsarian, C. (2012). A cost-effectiveness model of genetic testing for the evaluation of families with hypertrophic cardiomyopathy. Heart, 98(8), 625-630. [More Information]
  • Ingles, J., Yeates, L., O'Brien, L., McGaughran, J., Scuffham, P., Atherton, J., Semsarian, C. (2012). Genetic testing for inherited heart diseases: longitudinal impact on health-related quality of life. Genetics in Medicine, 14(8), 749-752. [More Information]
  • Ingles, J., Zodgekar, P., Yeates, L., Macciocca, I., Semsarian, C., Fatkin, D., Members of CSANZ Cardiac Genetic Diseases Council Writing Group, M. (2011). Guidelines for genetic testing of inherited cardiac disorders. Heart, Lung and Circulation, 20(11), 681-687. [More Information]
  • Bagnall, R., Ingles, J., Semsarian, C. (2011). Molecular diagnostics of cardiomyopathies: the future is here. Circulation Cardiovascular Genetics, 4(2), 103-104. [More Information]
  • Gray, B., Ingles, J., Semsarian, C. (2011). Natural history of genotype positive-phenotype negative patients with hypertrophic cardiomyopathy. International Journal of Cardiology, 152(2), 258-259. [More Information]
  • Ingles, J., Yeates, L., Semsarian, C. (2011). The emerging role of the cardiac genetic counselor. Heart Rhythm, 8(12), 1958-1962. [More Information]
  • Chiu, C., Bagnall, R., Ingles, J., Yeates, L., Kennerson, M., Donald, J., Jormakka, M., Lind, J., Semsarian, C. (2010). Mutations in Alpha-Actinin-2 Cause Hypertrophic Cardiomyopathy: A Genome-Wide Analysis. Journal of the American College of Cardiology, 55(11), 1127-1135. [More Information]
  • Ingles, J., McGaughran, J., Vohra, J., Weintraub, R., Davis, A., Atherton, J., Semsarian, C. (2008). Establishment of an Australian National Genetic Heart Disease Registry. Heart, Lung and Circulation, 17(6), 463-467. [More Information]
  • Ingles, J., Lind, J., Phongsavan, P., Semsarian, C. (2008). Psychosocial impact of specialized cardiac genetic clinics for hypertrophic cardiomyopathy. Genetics in Medicine, 10(2), 117-120. [More Information]
  • Chiu, C., Tebo, M., Ingles, J., Yeates, L., Arthur, J., Lind, J., Semsarian, C. (2007). Genetic screening of calcium regulation genes in familial hypertrophic cardiomyopathy. Journal of Molecular and Cellular Cardiology, 43, 337-343. [More Information]
  • Chiu, C., Ingles, J., Lind, J., Semsarian, C. (2006). Mutation analysis of the natriuretic peptide precursor B (NPPB) gene in patients with hypertrophic cardiomyopathy. DNA Sequence, 17(5), 392-395. [More Information]
  • Doolan, A., Tebo, M., Ingles, J., Nguyen, L., Tsoutsman, T., Lam, L., Chiu, C., Chung, J., Weintraub, R., Semsarian, C. (2005). Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences. Journal of Molecular and Cellular Cardiology, 38(2), 387-93. [More Information]
  • Ingles, J., Doolan, A., Chiu, C., Seidman, J., Seidman, C., Semsarian, C. (2005). Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling. Journal of Medical Genetics, 42(10), 1-6. [More Information]
  • Megevand, A., Ingles, J., Richmond, D., Semsarian, C. (2005). Long-term follow-up of patients with obstructive hypertrophic cardiomyopathy treated with dual-chamber pacing. The American Journal of Cardiology, 95(8), 991-993. [More Information]
  • Jayatilleke, I., Doolan, A., Ingles, J., McGuire, M., Booth, V., Richmond, D., Semsarian, C. (2004). Long-Term Follow-Up Of Implantable Cardioverter Defibrillator Therapy For Hypertrophic Cardiomyopathy. The American Journal of Cardiology, 93(9), 1192-1194. [More Information]
  • Doolan, G., Nguyen, L., Chung, J., Ingles, J., Semsarian, C. (2004). Progression Of Left Ventricular Hypertrophy And The Angiotensin-Converting Enzyme Gene Polymorphism In Hypertrophic Cardiomyopathy. International Journal of Cardiology, 96(2), 157-163.

Conferences

  • Neubeck, A., Lowres, N., Semsarian, C., Ingles, J., Johnston, S., Redfern, J. (2012). Social Media and Cardiac Rehabilitation: A Systematic Review. 22nd Australian Cardiovascular Health and Rehabilitation Association (ACRA) Annual Conference 2012, Brisbane, Queensland, Australia.

2014

  • Ingles, J., Semsarian, C. (2014). Conveying a probabilistic genetic test result to families with an inherited heart disease. Heart Rhythm, 11(6), 1073-1078. [More Information]
  • Das K, J., Ingles, J., Bagnall, R., Semsarian, C. (2014). Determining pathogenicity of genetic variants in hypertrophic cardiomyopathy: importance of periodic reassessment. Genetics in Medicine, 16(4), 286-293. [More Information]
  • Ingles, J., Semsarian, C. (2014). The value of cardiac genetic testing. Trends In Cardiovascular Medicine, 24(6), 217-224. [More Information]

2013

  • Ingles, J., Sarina, T., Yeates, L., Hunt, L., Macciocca, I., McCormack, L., Winship, I., McGaughran, J., Atherton, J., Semsarian, C. (2013). Clinical predictors of genetic testing outcomes in hypertrophic cardiomyopathy. Genetics in Medicine, 15(12), 972-977. [More Information]
  • Semsarian, C., Ingles, J. (2013). Expanding the genetic spectrum of hypertrophic cardiomyopathy: x marks the spot. Circulation Cardiovascular Genetics, 6(6), 528-530. [More Information]
  • Ingles, J., Yeates, L., Hunt, L., McGaughran, J., Scuffham, P., Atherton, J., Semsarian, C. (2013). Health status of cardiac genetic disease patients and their at-risk relatives. International Journal of Cardiology, 165(3), 448-453. [More Information]
  • Gray, B., Yeates, L., Medi, C., Ingles, J., Semsarian, C. (2013). Homozygous mutation in the cardiac troponin I gene: Clinical heterogeneity in hypertrophic cardiomyopathy. International Journal of Cardiology, 168(2), 1530-1531. [More Information]
  • Yeates, L., Hunt, L., Saleh, M., Semsarian, C., Ingles, J. (2013). Poor psychological wellbeing particularly in mothers following sudden cardiac death in the young. European Journal of Cardiovascular Nursing, 12(5), 484-491. [More Information]
  • Gray, B., Ingles, J., Medi, C., Semsarian, C. (2013). Prolongation of the QTc Interval Predicts Appropriate Implantable Cardioverter-Defibrillator Therapies in Hypertrophic Cardiomyopathy. JACC: Heart Failure, 1(2), 149-155. [More Information]
  • Ingles, J., Sarina, T., Kasparian, N., Semsarian, C. (2013). Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease. International Journal of Cardiology, 168(4), 3779-3784. [More Information]
  • Ingles, J., Semsarian, C. (2013). The Australian Genetic Heart Disease Registry. International Journal of Cardiology, 168(4), e127-e128. [More Information]
  • Redfern, J., Ingles, J., Neubeck, A., Johnston, S., Semsarian, C. (2013). Tweeting Our Way to Cardiovascular Health. Journal of the American College of Cardiology, 61(15), 1657-1658. [More Information]

2012

  • Ingles, J., McGaughran, J., Scuffham, P., Atherton, J., Semsarian, C. (2012). A cost-effectiveness model of genetic testing for the evaluation of families with hypertrophic cardiomyopathy. Heart, 98(8), 625-630. [More Information]
  • Ingles, J., Yeates, L., O'Brien, L., McGaughran, J., Scuffham, P., Atherton, J., Semsarian, C. (2012). Genetic testing for inherited heart diseases: longitudinal impact on health-related quality of life. Genetics in Medicine, 14(8), 749-752. [More Information]
  • Neubeck, A., Lowres, N., Semsarian, C., Ingles, J., Johnston, S., Redfern, J. (2012). Social Media and Cardiac Rehabilitation: A Systematic Review. 22nd Australian Cardiovascular Health and Rehabilitation Association (ACRA) Annual Conference 2012, Brisbane, Queensland, Australia.

2011

  • Ingles, J., Zodgekar, P., Yeates, L., Macciocca, I., Semsarian, C., Fatkin, D., Members of CSANZ Cardiac Genetic Diseases Council Writing Group, M. (2011). Guidelines for genetic testing of inherited cardiac disorders. Heart, Lung and Circulation, 20(11), 681-687. [More Information]
  • Bagnall, R., Ingles, J., Semsarian, C. (2011). Molecular diagnostics of cardiomyopathies: the future is here. Circulation Cardiovascular Genetics, 4(2), 103-104. [More Information]
  • Gray, B., Ingles, J., Semsarian, C. (2011). Natural history of genotype positive-phenotype negative patients with hypertrophic cardiomyopathy. International Journal of Cardiology, 152(2), 258-259. [More Information]
  • Ingles, J., Yeates, L., Semsarian, C. (2011). The emerging role of the cardiac genetic counselor. Heart Rhythm, 8(12), 1958-1962. [More Information]

2010

  • Chiu, C., Bagnall, R., Ingles, J., Yeates, L., Kennerson, M., Donald, J., Jormakka, M., Lind, J., Semsarian, C. (2010). Mutations in Alpha-Actinin-2 Cause Hypertrophic Cardiomyopathy: A Genome-Wide Analysis. Journal of the American College of Cardiology, 55(11), 1127-1135. [More Information]

2008

  • Ingles, J., McGaughran, J., Vohra, J., Weintraub, R., Davis, A., Atherton, J., Semsarian, C. (2008). Establishment of an Australian National Genetic Heart Disease Registry. Heart, Lung and Circulation, 17(6), 463-467. [More Information]
  • Ingles, J., Lind, J., Phongsavan, P., Semsarian, C. (2008). Psychosocial impact of specialized cardiac genetic clinics for hypertrophic cardiomyopathy. Genetics in Medicine, 10(2), 117-120. [More Information]

2007

  • Chiu, C., Tebo, M., Ingles, J., Yeates, L., Arthur, J., Lind, J., Semsarian, C. (2007). Genetic screening of calcium regulation genes in familial hypertrophic cardiomyopathy. Journal of Molecular and Cellular Cardiology, 43, 337-343. [More Information]

2006

  • Chiu, C., Ingles, J., Lind, J., Semsarian, C. (2006). Mutation analysis of the natriuretic peptide precursor B (NPPB) gene in patients with hypertrophic cardiomyopathy. DNA Sequence, 17(5), 392-395. [More Information]

2005

  • Doolan, A., Tebo, M., Ingles, J., Nguyen, L., Tsoutsman, T., Lam, L., Chiu, C., Chung, J., Weintraub, R., Semsarian, C. (2005). Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences. Journal of Molecular and Cellular Cardiology, 38(2), 387-93. [More Information]
  • Ingles, J., Doolan, A., Chiu, C., Seidman, J., Seidman, C., Semsarian, C. (2005). Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling. Journal of Medical Genetics, 42(10), 1-6. [More Information]
  • Megevand, A., Ingles, J., Richmond, D., Semsarian, C. (2005). Long-term follow-up of patients with obstructive hypertrophic cardiomyopathy treated with dual-chamber pacing. The American Journal of Cardiology, 95(8), 991-993. [More Information]

2004

  • Jayatilleke, I., Doolan, A., Ingles, J., McGuire, M., Booth, V., Richmond, D., Semsarian, C. (2004). Long-Term Follow-Up Of Implantable Cardioverter Defibrillator Therapy For Hypertrophic Cardiomyopathy. The American Journal of Cardiology, 93(9), 1192-1194. [More Information]
  • Doolan, G., Nguyen, L., Chung, J., Ingles, J., Semsarian, C. (2004). Progression Of Left Ventricular Hypertrophy And The Angiotensin-Converting Enzyme Gene Polymorphism In Hypertrophic Cardiomyopathy. International Journal of Cardiology, 96(2), 157-163.

To update your profile click here. For support on your academic profile contact .